Current Atrial Fibrillation News and Events

Current Atrial Fibrillation News and Events, Atrial Fibrillation News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Hypertension symptoms in women often mistaken for menopause
Pregnancy complications and early menopause increase women's future risk of heart disease. Cardiologists, gynaecologists and endocrinologists recommend how to help middle-aged women prevent later heart problems in a European Society of Cardiology (ESC) consensus document published today in European Heart Journal, a journal of the ESC. ''Physicians should intensify the detection of hypertension in middle-aged women,'' states the document. (2021-01-26)

Opportunities to better detect, manage and treat patients with undiagnosed atrial fibrillation
Atrial fibrillation (AF) is associated with a higher risk of complications including ischemic stroke, cognitive decline, heart failure, myocardial infarction and death. AF frequently is undetected until complications such as stroke or heart failure occur. A new report led by Boston University School of Medicine (BUSM) researcher Emelia J. Benjamin, MD, ScM, builds upon a recently conducted National Heart, Lung, and Blood Institute's virtual workshop that focused on identifying key research priorities related to AF screening. (2021-01-25)

Mayo Clinic study indicates age influences sex-related outcomes after heart attack
Approximately 1.5 million heart attacks and strokes occur every year in men and women in the US Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks. Mayo Clinic researchers discuss these sex and age differences in study findings published in Mayo Clinic Proceedings. (2021-01-20)

Geisinger researchers find sex is not an independent risk factor for stroke mortality
An analysis of data collected from patients treated for ischemic stroke at Geisinger shows no disparity in outcomes based solely on sex. (2021-01-19)

New drug form may help treat osteoporosis, calcium-related disorders
Purdue University innovators developed a stabilized form of human calcitonin, which is a peptide drug already used for people with osteoporosis. Researchers at Purdue created a prodrug form of the peptide hormone to increase its effectiveness as an osteoporosis treatment. (2021-01-06)

CVIA has just published a new issue, Volume 5 Issue 2
The journal Cardiovascular Innovations and Applications (CVIA) has just published the second issue of Volume 5. This issue brings together important research from authors in the USA and China, and includes new papers on 'Current Management Strategies in Patients with Heart Failure and Atrial Fibrillation' and 'Epicardial Adipose Tissue in Patients with Obstructive Sleep Apnea: A Systematic Review and Meta-analysis.' (2020-12-22)

Pulp succeeded in diet? Determining the slenderization of wood pulp
Osaka University scientists devise a system for measuring the quality of nanofibrillation for wood pulp using its natural optical birefringence. This work may lead to clear definition and sophisticated utilization of wooden cellulose nanofibers. (2020-12-17)

Women face higher risk of death or heart failure following a heart attack: study
Women face a 20 per cent higher risk than men of dying or having heart failure during the five years following a heart attack, according to a new study from University of Alberta cardiology researchers. (2020-12-15)

Why failing hearts love hard workouts
High-intensity interval training strengthens the heart even more than moderate exercise does. Now researchers have found several answers to what makes hard workouts so effective. (2020-12-10)

Study highlights strategies for boosting accuracy of personal genetic risk scores
As the consumer genetics industry rapidly expands, more and more people are turning to DNA-based services to learn their risk of developing a wide range of diseases. However, the risk scores from these genetic tests are not always as precise as they could be, according to a new study from Scripps Research. The scientists examine many approaches to calculating the scores and recommend that personal genomics organizations adopt standards that will raise the bar for accuracy. (2020-12-03)

Patients with heart rhythm disorder warned against heavy alcohol consumption
Fourteen drinks a week is linked with a higher risk of health problems including stroke and embolism in patients with atrial fibrillation, according to research published in EP Europace, a journal of the European Society of Cardiology (ESC). ''Our study suggests that atrial fibrillation patients should avoid heavy alcohol consumption to prevent stroke and other complications,'' said author Dr. Boyoung Joung of Yonsei University College of Medicine, Seoul, Republic of Korea. (2020-12-02)

Ongoing anticoagulant treatment does not seem to protect against severe COVID-19
DOAC (direct oral anticoagulant) pills are used in the treatment of atrial fibrillation by preventing blood clots. Even though blood clots are thought to contribute to complications from the new coronavirus infection, users of this class of drug do not seem to be protected against severe COVID-19, reports a large Swedish registry study from Karolinska Institutet published in The Journal of Internal Medicine. (2020-12-01)

Women found to be at higher risk for heart failure and heart attack death than men
Researchers found women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with men. In addition, women were more likely than men to be older and have a more complicated medical history at the time of their heart attacks. (2020-11-30)

Study: COVID-19 infection combined with blood clots worsen patient outcomes
While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with an increased tendency of the blood to clot, leading to a higher risk of death from COVID-19. (2020-11-23)

Hypertrophic cardiomyopathy guideline encourages shared decision-making
The American Heart Association and the American College of Cardiology today released an updated guideline for managing patients with hypertrophic cardiomyopathy (HCM). The guideline encourages shared decision-making between the clinician and patient as essential when determining treatment course and updates recommendations for sudden cardiac death (SCD) risk assessment and HCM center referrals based on the latest evidence. (2020-11-20)

Patients at risk of atrial fibrillation may need additional monitoring after heart surgery
There appears to be a high rate of unrecognized atrial fibrillation in the month following heart surgery among people who have an increased risk of stroke, even when atrial fibrillation was not detected immediately following surgery. When high-risk patients wore a heart monitor 24-hours a day for 30 days after heart surgery, atrial fibrillation was detected ten times more often than in patients who were not monitored continuously. (2020-11-16)

STRENGTH trial finds new fish oil medication did not reduce the risk of cardiac events
A medication derived from fish oil, containing the omega-3 fatty acids EPA and DHA, was evaluated in a large, international study of more than 13,000 people who had existing heart disease or who were at high risk of heart disease due to other medical conditions. The medication did not reduce the risk of cardiac events compared to a corn oil-based placebo in the STRENGTH trial. (2020-11-15)

Omega-3s did not reduce cardiac events in recent heart attack survivors
Omega-3 supplements in commonly available forms appear to be ineffective in preventing further cardiovascular events among elderly people with recent heart attacks. When compared to a placebo, an omega-3 fatty acids supplement in addition to statin therapy and/or a blood thinner did not reduce the number of cardiac events in a study of more than 1,000 patients in Norway. (2020-11-15)

Rivaroxaban may be as effective as warfarin for bioprosthetic mitral valves, AF
The RIVER trial is the largest study assessing the efficacy and safety of the anticoagulant rivaroxaban in patients with an artificial mitral valve to correct an irregular heart rhythm. Researchers concluded that rivaroxaban worked as well as the standard anticoagulant medication warfarin. (2020-11-14)

New medicine reduced risk for heart failure emergencies, hospital visits
Results from a large, Phase 3, global, cardiovascular outcomes study indicate a new medication may reduce the risk for heart failure-related events or cardiovascular deaths in people with chronic heart failure. (2020-11-13)

Intravenous iron reduced rehospitalization risk in people with heart failure
Iron deficiency is present in about 50% of people with chronic heart failure. Patients with heart failure who also have iron-deficiency are more likely to have poor outcomes. Intravenous iron replacement with ferric carboxymaltose reduced the risk of heart failure hospitalizations in patients with iron deficiency after an episode of acute heart failure. (2020-11-13)

Study: Vitamin D, fish oil don't lower atrial fibrillation risk
New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance. (2020-11-13)

Fish oil and vitamin D supplements not effective for preventing atrial fibrillation
About 2.7 million Americans are living with atrial fibrillation, an irregular heartbeat that can lead to blood clots, strokes, heart failure and other heart-related complications. Previous studies have not been able to confirm if vitamin D and omega-3 fatty acid supplements such as fish oil can prevent atrial fibrillation, while some studies have conflicting data about the risks and benefits of these supplements for patients with other health conditions. (2020-11-13)

Higher fitness levels linked to lower AFib risk in male, African American veterans
Higher fitness levels reduced the risk of developing an irregular heart rhythm, known as atrial fibrillation or AFib, by 30% to 50% in a study of male, African American veterans. Although only male, African American veterans were included in the study, researchers note the results suggest physical activity may reduce the risk of developing AFib among all adults. (2020-11-09)

COVID-19 risks: Irregular heartbeat may increase risk, blood pressure medicines do not
As the COVID-19 pandemic continues to affect people around the globe, research is ongoing to facilitate a greater understanding of the virus to improve patient care and outcomes. Heart health and medications and the potential role each have on patients with COVID-19 have been the focus of hundreds of studies. (2020-11-09)

Warfarin use significantly increases risk of knee and hip replacement in people with OA
New research shows that use of warfarin is associated with a significantly greater risk of knee and hip replacements in patients with OA. (2020-11-06)

Asian ethnicity strongly linked to COVID-related stroke
Asian ethnicity is strongly linked to COVID-related stroke, reveals an analysis of stroke centre activity in England and Scotland during the first wave of the coronavirus pandemic, and accepted for publication in the Journal of Neurology Neurosurgery & Psychiatry. (2020-11-05)

Effective stroke drugs are saving the NHS millions
Drugs prescribed to high-risk stroke patients are costing the NHS hundreds of millions each year - but they are so effective, the service is actually saving money. (2020-10-29)

Machine learning helps pinpoint sources of the most common cardiac arrhythmia
Researchers have designed a new ML-based approach for detecting atrial fibrillation drivers, small patches of the heart muscle that are hypothesized to cause this most common type of cardiac arrhythmia. The team tested their approach on 11 explanted human hearts, all donated posthumously for research purposes. Turned out, that their ML model can indeed efficiently interpret data with an accuracy of up to 81%. (2020-10-29)

Shot of alcohol can help an irregular heartbeat
Research out in this week's issue of JAMA confirms the success of a treatment for persistent atrial fibrillation (AFib) that combines the standard treatment, catheter ablation, with a separate infusion of ethanol, or alcohol, to the vein of Marshall. (2020-10-28)

New model predicts which patients with kidney disease may develop heartbeat irregularities
* A new model that incorporates a type of artificial intelligence can accurately predict which individuals with chronic kidney disease face a high risk of developing atrial fibrillation. * Results from the study will be presented online during ASN Kidney Week 2020 Reimagined October 19-October 25. (2020-10-24)

ASTRO: Proton therapy for lung cancer may help reduce risk of heart diseases
Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases. (2020-10-23)

CVIA has just published a new issue, Volume 5 Issue 1
The journal Cardiovascular Innovations and Applications (CVIA) has just published the first issue of Volume 5. Included in the issue is a paper of major importance on Serum Procalcitonin Levels on Admission Predict Death in Severe and Critical COVID-19 Patients in Wuhan, China (2020-10-19)

Big babies could be at higher risk of common heart rhythm disorder in adulthood
Elevated birth weight is linked with developing atrial fibrillation later in life, according to research presented at the 31st Great Wall International Congress of Cardiology (GW-ICC). (2020-10-18)

What fuels the beating heart? Study reveals nutrients used by normal and failing hearts
A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has produced a detailed picture of fuel and nutrient use by the human heart. The study was the first of its kind, involving the simultaneous sampling of blood from different parts of the circulatory system in dozens of human participants, in order to record the levels of related molecules going into and coming out of the beating heart. (2020-10-15)

Results from the MITHRAS trial reported at TCT Connect and published in Circulation
The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six-minute walking distance. (2020-10-15)

Catheter ablation linked to reduced risk of dementia in patients with atrial fibrillation
People with atrial fibrillation have a reduced risk of dementia if they undergo a procedure called catheter ablation to restore the normal rhythm of their heart, according to a new study published in the European Heart Journal that analyses over 27,000 patients with newly diagnosed atrial fibrillation out of a population of nearly a million people. (2020-10-06)

Study identifies weight-loss threshold for heart health in patients with obesity, diabetes
A Cleveland Clinic study shows that 5 to 10 percent of surgically induced weight loss is associated with improved life expectancy and cardiovascular health. In comparison, about 20 percent weight loss is necessary to observe similar benefits with a non-surgical treatment. The findings also show that metabolic surgery may contribute health benefits that are independent of weight loss. The study is published in the October issue of Annals of Surgery. (2020-09-23)

Pollution exposure linked to stroke risk in people with common heart rhythm disorder
People with atrial fibrillation who are exposed to greater levels of pollution have a higher risk of stroke than their peers who live with less pollution. (2020-09-16)

BIO Integration Journal, Volume 1, Issue Number 2, publishes
New journal BIO Integration (BIOI) publishes its second issue, volume 1, issue 2. (2020-09-09)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.